Filters

Cecropin (1D8) Antibody, Cy3 Conjugated

Cecropin (1D8) Antibody, Cy3 Conjugated size: 0.1ml 350

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 350
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name Cy3 Conjugated, Cecropin (1D8) Monoclonal Antibody
CategoryConjugated Primary Antibodies
Conjugationcy3 conjugation kit
Host OrganismMouse (Mus musculus)
Target AntigenCecropin
SpecificityThis is a highly specific antibody against Cecropin
ModificationUnmodified
Modification siteNone
ClonalityMonoclonal
Clone1D8
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from Hyalophora cecropia
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
CrossreactivityOther Species
Crossreactive species detailsHyalophora cecropia
Antigen backgroundNo data available
Purification methodPurified by Protein G
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission512, 550nm/570, 615nm
Synonymsattacin
Properties 1 of the Cecropin (1D8) Antibody, Conjugated can be used in flow cytometry but typically shows lower fluorescence intensity comparable to that of PE or APC, Cy3 antibodies are excited by the 488-nanometer wave of an argon laser and the 633-nanometer line of a helium-neon diode laser, This Bioss Primary Conjugated Antibodies antibody is well suited for fluorescent microscopy, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetCecropin (1D8) Conjugated
Short name Conjugated, Cecropin (1D8) Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy3
Alternative name cyanine 3 coupled, Cecropin (1D8) (Antibody to)
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter